Differential Expression of miRNA-192 is a Potential Biomarker for HIV Associated Immune Recovery Uveitis

References

• Urban B, Bakunowicz-łazarczyk A, Michalczuk M. Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment. Med Inflamm. 2014;2014:1–10.
   Web of Science ®Google Scholar
• Lai RPJ, Meintjes G, Wilkinson KA, et al. HIV–tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling. Nat Communi. 2015;6:1–11.
   Web of Science ®Google Scholar
• Suthar AB, Lawn SD, Amo J, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med. 2012;9:1–15. doi:10.1371/journal.pmed.1001270.
   Web of Science ®Google Scholar
• Walker NF, Graeme M, Robert JW. HIV-1 and the immune response to TB. Future virol. 2013;8:57–80. doi:10.2217/fvl.12.123.
   PubMed Web of Science ®Google Scholar
• Narendran G, Andrade BB, Porter BO, et al. Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction. PloS one. 2013;8:1–8. doi:10.1371/journal.pone.0063541.
   Web of Science ®Google Scholar
• Agrawal RV, Murthy S, Sangwan V, Biswas J. Current approach in diagnosis and management of anterior uveitis. Indian J Ophthalmol. 2010;58:11–19. doi:10.4103/0301-4738.58468.
   PubMed Web of Science ®Google Scholar
• Sudharshan S, Kaleemunnisha S, Banu AA, et al. Ocular lesions in 1,000 consecutive HIV-positive patients in India: a long-term study. J Ophthalmic Inflamm Infect. 2013;3:1–7. doi:10.1186/1869-5760-3-2.
   PubMedGoogle Scholar
• Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. Aids. 2005;19:399–406. doi:10.1097/01.aids.0000161769.06158.8a.
   PubMed Web of Science ®Google Scholar
• Sudharshan S, Nair N, Curi A, Banker A, Kempen JH. Human immunodeficiency virus and intraocular inflammation in the era of highly active anti retroviral therapy–An update. Indian J Ophthalmol. 2020;68:1787–1798. doi:10.4103/ijo.IJO_1248_20.
   PubMed Web of Science ®Google Scholar
• Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677–704. doi:10.1146/annurev.immunol.26.021607.090331.
   PubMed Web of Science ®Google Scholar
• Cunningham ET Jr, Todd PM. Ocular manifestations of HIV infection. N J Engl Med. 1998;339:236–244. doi:10.1056/NEJM199807233390406.
   PubMed Web of Science ®Google Scholar
• Bowen LN, Smith B, Reich D, Quezado M, Nath A. HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment. Nat Rev Neurol. 2016;12:662–674. doi:10.1038/nrneurol.2016.149.
   PubMed Web of Science ®Google Scholar
• Gottwein E. Roles of microRNAs in the life cycles of mammalian viruses. IntrImm. 2013;371:201–227.
   Google Scholar
• Hariharan M, Scaria V, Pillai B, Brahmachari SK. Targets for human encoded microRNAs in HIV genes. Biochem Biophys Res Comm. 2005;337:1214–1218. doi:10.1016/j.bbrc.2005.09.183.
   PubMed Web of Science ®Google Scholar
• Yeung ML, Bennasser Y, Myers TG, et al. Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology. 2005;2:1–8. doi:10.1186/1742-4690-2-81.
   PubMed Web of Science ®Google Scholar
• Gupta A, Nagilla P, Le H, et al. Comparative expression profile of miRNA and mRNA in primary peripheral blood mononuclear cells infected with human immunodeficiency virus (HIV-1). PloS One. 2011;6:1–12. doi:10.1371/journal.pone.0022730.
   Web of Science ®Google Scholar
• Swaminathan S, Murray DD, Kelleher AD. The role of microRNAs in HIV-1 pathogenesis and therapy. Aids. 2012;26:1325–1334. doi:10.1097/QAD.0b013e328352adca.
   PubMed Web of Science ®Google Scholar
• Fayyad-kazan H, Bitar N, Najar M, et al. Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J Translat. Med. 2013;11:1–10. doi:10.1186/1479-5876-11-31.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A. 2009;106:4402–4407. doi:10.1073/pnas.0813371106.
   PubMed Web of Science ®Google Scholar
• Waidmann O, Bihrer V, Pleli T, et al. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. JViralHepat. 2012;19:58–65.
   Google Scholar
• Bihrer V, Friedrich-rust M, Kronenberger B, et al. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 2011;106:1663–1669. doi:10.1038/ajg.2011.161.
   PubMed Web of Science ®Google Scholar
• Adachi T, Nakanishi M, Otsuka Y, et al. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem. 2010;56:1183–1185. doi:10.1373/clinchem.2010.144121.
   PubMed Web of Science ®Google Scholar
• Kempen JH, Min Y, Freeman WR, Holland GN; Studies of Ocular Complications of AIDS Research Group. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmol. 2006;113:684–694. doi:10.1016/j.ophtha.2005.10.067.
   PubMed Web of Science ®Google Scholar
• Vignesh R, Swathirajan CR, Solomon SS, et al. Risk factors and frequency of tuberculosis-associated immune reconstitution inflammatory syndrome among HIV/Tuberculosis co-infected patients in Southern India. Indian J Med Microbiol. 2017;35:279–281. doi:10.4103/ijmm.IJMM_16_163.
   PubMed Web of Science ®Google Scholar
• Krishnan G, Chatterjee N. Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity. Mol CellNeurosci. 2014;59:10–23.
   Web of Science ®Google Scholar
• Krishnan G, Chatterjee N. Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA. Sci Rep. 2015;5:1–16.
   Web of Science ®Google Scholar
• Stek C, Menten J, Schutz C, et al. Diagnostic accuracy of the INSHI consensus case definition for the diagnosis of paradoxical tuberculosis-IRIS. J AcqImm Defi Synd. 2021;86:587–592.
   PubMed Web of Science ®Google Scholar
• Rodger AJ, Fox Z, Lundgren JD, et al. for the INSIGHT strategies for management of antiretroviral therapy (SMART) study group, activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis. 2009;200:973–983. doi:10.1086/605447.
   PubMed Web of Science ®Google Scholar
• Pathai S, Deshpande A, Gilbert C, Lawn SD. Lawn SD.Prevalence of HIV-associated ophthalmic disease among patients enrolling for antiretroviral treatment in India: a cross-sectional study. BMC Infect Dis. 2009;9(1):1–9. doi:10.1186/1471-2334-9-158.
   PubMedGoogle Scholar
• Miller C, Perez-povis L, Lontok J, et al. The spectrum of eye disease in hospitalized adults living with HIV, 1995–2010. AIDS Patient Care STDs. 2014;28:47–55. doi:10.1089/apc.2013.0258.
   PubMed Web of Science ®Google Scholar
• Robinson MR, George R, Karl GC, et al. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. A J Ophthalmol. 2000;130:49–56. doi:10.1016/S0002-9394(00)00530-4.
   Google Scholar
• Neill LAO, Sheedy FJ, Mccoy CE, et al. MicroRNAs: the fine-tuners of Toll-like receptor signaling. Nat Rev Immunol. 2011;11:163–175. doi:10.1038/nri2957.
   PubMed Web of Science ®Google Scholar
• Kannangai R, Ramalingam S, Jesudason MV, et al. Correlation of CD4+ T-Cell counts estimated by an immunocapture technique (Capcellia) with viral loads in human immunodeficiency virus-seropositive individuals. Clin Diag Lab Immunol. 2001;8:1286–1288. doi:10.1128/CDLI.8.6.1286-1288.2001.
   PubMedGoogle Scholar
• Lischka J, Schanzer A, Hojreh A, et al. Circulating microRNAs 34a, 122, and 192 are linked to obesity-associated inflammation and metabolic disease in pediatric patients. Intl Jobes. 2021;45:1763–1772.
   Web of Science ®Google Scholar
• Hernández-walias F, Mjr- L, Rosado-sánchez I, et al. New signatures of poor CD4 cell recovery after suppressive antiretroviral therapy in HIV-1-infected individuals: involvement of miR-192, IL-6, sCD14 and miR-144. Sci Rep. 2020;10:1–11. doi:10.1038/s41598-020-60073-8.
   PubMed Web of Science ®Google Scholar
• Zheng J, Zhu L, Iok I, et al. Bone marrow-derived mesenchymal stem cells-secreted exosomal microRNA-192-5p delays inflammatory response in rheumatoid arthritis. Intl Immunopharmacol. 2020;78:1–10. doi:10.1016/j.intimp.2019.105985.
   Web of Science ®Google Scholar
• Zhao F, Dang Y, Zhang R, et al. Apigenin attenuates acrylonitrile-induced neuro-inflammation in rats: involved of inactivation of the TLR4/NF-κB signaling pathway. Intl Immunopharmacol. 2019;75:1–12. doi:10.1016/j.intimp.2019.105697.
   Web of Science ®Google Scholar